Yusuke Nakano

Okazaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

C-reactive Protein-to-Albumin Ratio for Evaluating Patients with Chronic Limb-Threatening Ischemia Following Endovascular Therapy.

C-reactive Protein-to-Albumin Ratio for Evaluating Patients with Chronic Limb-Threatening Ischemia Following Endovascular Therapy.

Journal: Journal of atherosclerosis and thrombosis

Published: June 21, 2026

Triglyceride deposit cardiomyovasculopathy as a predictor of vascular failure after coronary intervention in patients with hemodialysis: a preliminary analysis.

Triglyceride deposit cardiomyovasculopathy as a predictor of vascular failure after coronary intervention in patients with hemodialysis: a preliminary analysis.

Journal: Renal failure

Published: April 22, 2026

Astrocyte Activation in the Hippocampus Following Cardiopulmonary Bypass in a Rat Model: A Pilot Study.

Astrocyte Activation in the Hippocampus Following Cardiopulmonary Bypass in a Rat Model: A Pilot Study.

Journal: Cureus

Published: January 13, 2026

Platypnea-Orthodeoxia Syndrome Associated With a Right-to-Left Cardiac Shunt Detected by Lung Perfusion Scintigraphy.

Platypnea-Orthodeoxia Syndrome Associated With a Right-to-Left Cardiac Shunt Detected by Lung Perfusion Scintigraphy.

Journal: The American journal of case reports

Published: December 23, 2025

Triglyceride deposit cardiomyovasculopathy: A new class of cardiovascular disease.

Triglyceride deposit cardiomyovasculopathy: A new class of cardiovascular disease.

Journal: Journal of cardiology

Published: December 19, 2025

Association Between Sarcopenic Obesity-Related Scores and Liver Fibrosis in Patients with Steatotic Liver Disease: A Cross-Sectional Study.

Association Between Sarcopenic Obesity-Related Scores and Liver Fibrosis in Patients with Steatotic Liver Disease: A Cross-Sectional Study.

Journal: Diagnostics (Basel, Switzerland)

Published: November 05, 2025

Dose-dependent renoprotective effects of sacubitril/valsartan in heart failure: a retrospective study.

Dose-dependent renoprotective effects of sacubitril/valsartan in heart failure: a retrospective study.

Journal: Renal failure

Published: August 22, 2025

Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease.

Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease.

Journal: World journal of hepatology

Published: June 13, 2025

Early Withdrawal From Continuous Intravenous Infusion and Delirium in Heart Failure.

Early Withdrawal From Continuous Intravenous Infusion and Delirium in Heart Failure.

Journal: JACC. Asia

Published: May 07, 2025

Impact of weight loss and lifestyle modifications on liver fibrosis in MASLD and MetALD: A cohort study.

Impact of weight loss and lifestyle modifications on liver fibrosis in MASLD and MetALD: A cohort study.

Journal: Biomedical reports

Published: March 12, 2025

Grip strength is a strong indicator of osteoporosis in both women and men with chronic liver disease.

Grip strength is a strong indicator of osteoporosis in both women and men with chronic liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 26, 2024

Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3.

Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3.

Journal: Internal medicine (Tokyo, Japan)

Published: September 18, 2024

Showing 1-12 of 85

Last Updated: 09/26/2026